Chewy, Inc.

Rule 10b5-1 Plan Elections

On January 16, 2026, Sumit Singh, the Company’s Chief Executive Officer, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on January 29, 2027, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 612,185 shares.

On January 16, 2026, Aseemita Malhotra, the Company’s President of Healthcare, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and is scheduled to expire on January 29, 2027, subject to earlier termination in accordance with its terms. The aggregate number of shares of Class A common stock authorized to be sold pursuant to the trading arrangement is 76,710 shares.

During the thirteen weeks ended February 1, 2026, no other director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted, modified, orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement”, as such terms are defined under Item 408 of Regulation S-K.

Adoption of Amended and Restated Bylaws

On March 24, 2026, the Board approved an amendment and restatement of the Company's bylaws (as amended, the “Bylaws”), effective immediately, to (i) revise and clarify the scope of certain procedures and disclosure requirements set forth in the Bylaws for stockholders to provide advance notice of director nominations and business proposals to be brought at a meeting of stockholders (other than proposals submitted pursuant to Rule 14a-8 under the Exchange Act), and (ii) make other administrative, modernizing, clarifying and conforming changes. The foregoing summary is qualified in its entirety by reference to the full text of the Bylaws, which are attached hereto as Exhibit 3.2 and incorporated herein by reference.